Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Boston-based synthetic biology company Ginkgo Bioworks has launched a biosecurity initiative to help predict biological warfare and infectious disease threats. For Ginkgo, the initiative incorporates existing contracts totaling up to $64 million from the U.S. Intelligence Advanced Research Projects Activity (IARPA), the Department of Defense, and the Department of Homeland Security. For one IARPA-sponsored project, Ginkgo will develop algorithms along with Battelle, One Codex, and Twist Bioscience to detect potential threats from known and unknown DNA sequences.
This article has been sent to the following recipient: